PG2604-PJT8819-COL018543-D1D-red-grey-900x300-D1-final

Discover tools and solutions to enable advancements in Reproductive Health.

Please fill out the form below to register for our exhibit theatre presentation or schedule a meeting with our experts to learn more about our latest solutions.

Jonathan-Stein-Headshot2

Beyond Metabolism: Looking to the Future of Expansion for Pharmacogenomics

Pharmacogenomics (PGx) is a precision medicine approach that adjusts drug selection and dosage according to an individual patient’s unique genome. In 2021, the US Food and Drug Administration (FDA) added a dozen drugs to its list of PGx-associated medications. However, the PGx of several well‑characterized, clinically relevant genetic variants are not currently being applied. Dr. Stein will review some of the considerations around PGx and PGx-associated research and development, and research associated with genetic variants that are associated with adverse responses to anesthesia.

Speaker: Jonathan Stein, PhD HCLD(ABB), Chief Science Officer/Medical Directors
Date: Friday, March 25, 2022
Time: 11:55 am – 12:25 pm
 Add to calendar ›

 Register for the Exhibit Theatre Presentation
 Schedule a meeting with our experts (in-person or virtually) and learn more about Reproductive Health and Inherited Disease solutions

* Required field

*
*
*
*
*
*
*
 
 Next-generation sequencing (NGS)
 Chromosomal Microarray (CMA)
 Plastics
 Other

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.